Treatment of renal artery in-stent restenosis with sirolimus-eluting stents

Vascular Medicine

Volumn 15, Issue 1, 2010, Pages 3-7

  Kiernan, Thomas J ^a   Yan, Bryan P ^a   Eisenberg, Jonathan D ^a   Ruggiero, Nicholas J ^a   Gupta, Vishal ^a   Drachman, Douglas ^a   Schainfeld, Robert M ^a   Jaff, Michael R ^a   Rosenfield, Kenneth ^a   Garasic, Joseph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Hypertension; In stent restenosis; Renal artery stenosis; Sirolimus

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATININE; CYPHER; HEPARIN; IODIXANOL; RAPAMYCIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CREATININE BLOOD LEVEL; DRUG ELUTING STENT; ECHOGRAPHY; FEMALE; FOLLOW UP; GENDER BIAS; HUMAN; IN-STENT RESTENOSIS; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RENAL ARTERY; RETROSPECTIVE STUDY; SEX RATIO; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; CARDIOVASCULAR AGENTS; DRUG-ELUTING STENTS; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION, RENOVASCULAR; KIDNEY; MALE; MIDDLE AGED; RECURRENCE; RENAL ARTERY OBSTRUCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SIROLIMUS; STENTS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 76049120026     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X09106897     Document Type: Article

References (14)

1. Lederman RJ, Mendelsohn FO, Santos R., Phillips HR, Stack RS, Crowley JJ Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J 2001 ; 142: 314-323.
2. Otah KE, Alhaddad IA Intravascular ultrasound-guided cutting balloon angioplasty for renal artery stent restenosis. Clin Cardiol 2004 ; 27: 581-583.
3. Bax L., Mali WP, Van De Ven PJ, et al. Repeated intervention for in-stent restenosis of the renal arteries. J Vasc Interv Radiol 2002 ; 13: 1219-1224.
4. Kakkar AK, Fischi M., Narins CR Drug-eluting stent implantation for treatment of recurrent renal artery in-stent restenosis. Catheter Cardiovasc Interv 2006 ; 68: 118-122.
5. Zeller T., Sixt S., Rastan A., et al. Treatment of reoccurring in-stent restenosis following reintervention after stent-supported renal artery angioplasty. Catheter Cardiovasc Interv 2007 ; 70: 296-300.
6. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003 ; 349: 1315-1323.
7. Zeller T., Rastan A., Rothenpieler U., Müller C. Restenosis after stenting of atherosclerotic renal artery stenosis: is there a rationale for the use of drug-eluting stents? Catheter Cardiovasc Interv 2006 ; 68: 125-130. (Pubitemid 44024474)
8. White CJ, Ramee SR, Collins TJ, Jenkins JS, Escobar A., Shaw D. Renal artery stent placement: utility in lesions difficult to treat with balloon angioplasty. J Am Coll Cardiol 1997 ; 30: 1445-1450.
9. Rundback JH, Sacks D., Kent KC, et al. Guidelines for the reporting of renal artery revascularization in clinical trials. American Heart Association. Circulation 2002 ; 106: 1572-1585. (Pubitemid 35050888)
10. Galin I., Trost B., Kang J., et al. Validation of renal duplex ultrasound in detecting renal artery stenosis post-stenting. Presented at the American College of Cardiology Annual Scientific Meeting, Chicago, 2008. Abstract A 317.
11. Tollefson DFJ, Ernst CB Natural history of atherosclerotic renal artery stenosis associated with aortic disease. J Vasc Surg 1991 ; 14: 327-331.
12. Zierler RE, Bergelin RO, Davidson RC, et al. A prospective study of disease progression in patients with atherosclerotic renal artery stenosis. Am J Hypertens 1996 ; 9: 1055-1061.
13. Neumann FJ, Desmet W., Grube E., et al. Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation 2005 ; 111: 2107-2111.
14. Zähringer M., Sapoval M., Pattynama PMT, et al. Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT trial): angiographic follow-up after 6 months and clinical outcome up to 2 years. J Endovasc Ther 2007 ; 14: 460-468.